aTyr Pharma, Inc. (ATYR)
NASDAQ: ATYR · Real-Time Price · USD
0.8274
+0.0191 (2.36%)
At close: Mar 23, 2026, 4:00 PM EDT
0.8399
+0.0125 (1.51%)
After-hours: Mar 23, 2026, 4:26 PM EDT
Revenue by Segment
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|
| Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | Dec '18 Dec 31, 2018 | Dec '17 Dec 31, 2017 | Dec '16 Dec 31, 2016 |
|---|
| 190.00K | 235.00K | 353.00K | 10.39M | | 10.46M | | | | |
Biotechnology (Startups) Growth | -19.15% | -33.43% | -96.60% | - | | 2377.49% | | | | |
| 190.00K | 235.00K | 353.00K | 10.39M | | 10.46M | | | | |
| -19.15% | -33.43% | -96.60% | - | | 2377.49% | | | | |
Source: S&P Global Market Intelligence.
